Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang LS, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR; Alzheimer’s Disease Genetics Consortium.

Nat Commun. 2020 Feb 3;11(1):667. doi: 10.1038/s41467-019-14279-8.

2.

Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.

Gatchel JR, Lopera F, Norton DJ, Baena A, Guzman-Velez E, Sanchez JS, d'Oleire Uquillas F, Schultz A, Vannini P, Artola A, Amariglio RE, Rentz DM, Tariot PN, Reiman EM, Johnson KA, Sperling RA, Marshall GA, Quiroz YT.

J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):330-332. doi: 10.1136/jnnp-2019-321205. Epub 2019 Dec 24. No abstract available.

PMID:
31874859
3.

Validation of the Latin American Spanish version of the face-name associative memory exam in a Colombian Sample.

Vila-Castelar C, Papp KV, Amariglio RE, Torres VL, Baena A, Gomez D, Rendon J, Samaroo A, Lopera F, Rentz DM, Quiroz YT.

Clin Neuropsychol. 2019 Dec 18:1-12. doi: 10.1080/13854046.2019.1690050. [Epub ahead of print]

PMID:
31851865
4.

Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.

Arboleda-Velasquez JF, Lopera F, O'Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, Leyton-Cifuentes D, Chen K, Baena A, Aguillon D, Rios-Romenets S, Giraldo M, Guzmán-Vélez E, Norton DJ, Pardilla-Delgado E, Artola A, Sanchez JS, Acosta-Uribe J, Lalli M, Kosik KS, Huentelman MJ, Zetterberg H, Blennow K, Reiman RA, Luo J, Chen Y, Thiyyagura P, Su Y, Jun GR, Naymik M, Gai X, Bootwalla M, Ji J, Shen L, Miller JB, Kim LA, Tariot PN, Johnson KA, Reiman EM, Quiroz YT.

Nat Med. 2019 Nov;25(11):1680-1683. doi: 10.1038/s41591-019-0611-3. Epub 2019 Nov 4.

PMID:
31686034
5.

Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.

Gatchel JR, Rabin JS, Buckley RF, Locascio JJ, Quiroz YT, Yang HS, Vannini P, Amariglio RE, Rentz DM, Properzi M, Donovan NJ, Blacker D, Johnson KA, Sperling RA, Marshall GA; Harvard Aging Brain Study.

JAMA Netw Open. 2019 Aug 2;2(8):e198964. doi: 10.1001/jamanetworkopen.2019.8964.

6.

Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults.

Rabin JS, Klein H, Kirn DR, Schultz AP, Yang HS, Hampton O, Jiang S, Buckley RF, Viswanathan A, Hedden T, Pruzin J, Yau WW, Guzmán-Vélez E, Quiroz YT, Properzi M, Marshall GA, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP.

JAMA Neurol. 2019 Jul 16. doi: 10.1001/jamaneurol.2019.1879. [Epub ahead of print]

PMID:
31312836
7.

Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registry.

Torres VL, Vila-Castelar C, Bocanegra Y, Baena A, Guzmán-Vélez E, Aguirre-Acevedo DC, Tirado V, Munoz C, Henao E, Moreno S, Giraldo M, Acosta N, Rios Romenets S, Langbaum JB, Cho W, Reiman EM, Tariot PN, Rosselli M, Quiroz YT, Lopera F.

Appl Neuropsychol Adult. 2019 Jun 23:1-15. doi: 10.1080/23279095.2019.1627357. [Epub ahead of print]

PMID:
31230490
8.

Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study.

Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, Huijbers W, Hedden T, Marshall GA, Chhatwal JP, Rentz DM, Sperling RA, Johnson K.

JAMA Neurol. 2019 Jun 3. doi: 10.1001/jamaneurol.2019.1424. [Epub ahead of print] Erratum in: JAMA Neurol. 2019 Aug 1;76(8):986.

9.

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.

Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, Sperling RA, Reiman EM, Lopera F, Quiroz YT.

J Prev Alzheimers Dis. 2019;6(2):112-120. doi: 10.14283/jpad.2019.6.

10.

Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr).

Ramirez Aguilar L, Acosta-Uribe J, Giraldo MM, Moreno S, Baena A, Alzate D, Cuastumal R, Aguillón D, Madrigal L, Saldarriaga A, Navarro A, Garcia GP, Aguirre-Acevedo DC, Geier EG, Cochran JN, Quiroz YT, Myers RM, Yokoyama JS, Kosik KS, Lopera F.

Alzheimers Dement. 2019 May;15(5):709-719. doi: 10.1016/j.jalz.2018.12.010. Epub 2019 Feb 10.

PMID:
30745123
11.

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.

Hanseeuw BJ, Lopera F, Sperling RA, Norton DJ, Guzman-Velez E, Baena A, Pardilla-Delgado E, Schultz AP, Gatchel J, Jin D, Chen K, Reiman EM, Johnson KA, Quiroz YT.

Alzheimers Res Ther. 2019 Feb 4;11(1):17. doi: 10.1186/s13195-019-0468-1.

12.

Clinical and research applications of magnetic resonance imaging in the study of CADASIL.

Schoemaker D, Quiroz YT, Torrico-Teave H, Arboleda-Velasquez JF.

Neurosci Lett. 2019 Apr 17;698:173-179. doi: 10.1016/j.neulet.2019.01.014. Epub 2019 Jan 8. Review.

PMID:
30634011
13.

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O'Bryant SE; International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association.

Alzheimers Dement. 2019 Feb;15(2):292-312. doi: 10.1016/j.jalz.2018.09.009. Epub 2018 Dec 13.

14.

The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.

Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T, Marshall GA, Quiroz YT, Donovan NJ, Jackson J, Gatchel JR, Rabin JS, Jacobs H, Yang HS, Properzi M, Kirn DR, Rentz DM, Johnson KA.

Ann Neurol. 2019 Feb;85(2):181-193. doi: 10.1002/ana.25395. Epub 2019 Jan 21.

15.

Event-related potential correlates of recognition memory in asymptomatic individuals with CADASIL.

Rendon J, Zuluaga Y, Velilla L, Ochoa J, Arboleda-Velasquez JF, Budson A, Lopera F, Quiroz YT.

Brain Res. 2019 Mar 15;1707:74-78. doi: 10.1016/j.brainres.2018.11.016. Epub 2018 Nov 13.

PMID:
30445028
16.

A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.

Guzmán-Vélez E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, Papp KV, Amariglio R, Rentz D, Baena A, Henao E, Tirado V, Muñoz C, Giraldo M, Sperling RA, Lopera F, Quiroz YT.

J Alzheimers Dis. 2018;65(1):107-115. doi: 10.3233/JAD-180078.

17.

Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.

Penny W, Iglesias-Fuster J, Quiroz YT, Lopera FJ, Bobes MA.

J Alzheimers Dis. 2018;65(3):697-711. doi: 10.3233/JAD-170405.

18.

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.

Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KA.

JAMA Neurol. 2018 May 1;75(5):548-556. doi: 10.1001/jamaneurol.2017.4907.

19.

Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.

Norton DJ, Amariglio R, Protas H, Chen K, Aguirre-Acevedo DC, Pulsifer B, Castrillon G, Tirado V, Munoz C, Tariot P, Langbaum JB, Reiman EM, Lopera F, Sperling RA, Quiroz YT.

Neurology. 2017 Oct 3;89(14):1464-1470. doi: 10.1212/WNL.0000000000004533. Epub 2017 Sep 6.

20.

Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.

Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, Sperling RA.

Alzheimers Dement. 2017 Sep;13(9):1004-1012. doi: 10.1016/j.jalz.2017.01.018. Epub 2017 Feb 28.

21.

Blood biomarkers in a mouse model of CADASIL.

Primo V, Graham M, Bigger-Allen AA, Chick JM, Ospina C, Quiroz YT, Manent J, Gygi SP, Lopera F, D'Amore PA, Arboleda-Velasquez JF.

Brain Res. 2016 Aug 1;1644:118-26. doi: 10.1016/j.brainres.2016.05.008. Epub 2016 May 10.

22.

Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.

Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Muñoz C, Giraldo M, Bangdiwala SI, Reiman EM, Tariot PN, Langbaum JB, Quiroz YT, Jaimes F.

JAMA Neurol. 2016 Apr;73(4):431-8. doi: 10.1001/jamaneurol.2015.4851.

23.

Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.

Quiroz YT, Willment KC, Castrillon G, Muniz M, Lopera F, Budson A, Stern CE.

J Alzheimers Dis. 2015;47(4):955-64. doi: 10.3233/JAD-150214.

24.

Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.

Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, Giraldo M, Tirado V, Ramírez DL, Tariot PN, Dickerson BC, Sperling RA, Lopera F, Reiman EM.

JAMA Neurol. 2015 Aug;72(8):912-9. doi: 10.1001/jamaneurol.2015.1099.

25.

Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez Gomez M, Langois CM, Langbaum JB, Roontiva A, Thiyyagura P, Lee W, Ayutyanont N, Lopez L, Moreno S, Muñoz C, Tirado V, Acosta-Baena N, Fagan AM, Giraldo M, Garcia G, Huentelman MJ, Tariot PN, Lopera F, Reiman EM.

JAMA Neurol. 2015 Mar;72(3):316-24. doi: 10.1001/jamaneurol.2014.3314.

26.

Ushering in the study and treatment of preclinical Alzheimer disease.

Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM.

Nat Rev Neurol. 2013 Jul;9(7):371-81. doi: 10.1038/nrneurol.2013.107. Epub 2013 Jun 11. Review. Erratum in: Nat Rev Neurol. 2013 Aug;9(8):418.

27.

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, Langbaum JB, Ayutyanont N, Roontiva A, Thiyyagura P, Lee W, Mo H, Lopez L, Moreno S, Acosta-Baena N, Giraldo M, Garcia G, Reiman RA, Huentelman MJ, Kosik KS, Tariot PN, Lopera F, Reiman EM.

Lancet Neurol. 2012 Dec;11(12):1057-65. doi: 10.1016/S1474-4422(12)70227-2. Epub 2012 Nov 6.

28.

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, Giraldo M, Acosta-Baena N, Sperling RA, Dickerson B, Stern CE, Tirado V, Munoz C, Reiman RA, Huentelman MJ, Alexander GE, Langbaum JB, Kosik KS, Tariot PN, Lopera F.

Lancet Neurol. 2012 Dec;11(12):1048-56. doi: 10.1016/S1474-4422(12)70228-4. Epub 2012 Nov 6.

29.

Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.

Quiroz YT, Stern CE, Reiman EM, Brickhouse M, Ruiz A, Sperling RA, Lopera F, Dickerson BC.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):556-61. doi: 10.1136/jnnp-2012-303299. Epub 2012 Nov 7.

30.

Charting the path for early diagnosis and prevention of Alzheimer's disease.

Quiroz YT, Lopera F, Budson AE.

Expert Rev Neurother. 2011 Dec;11(12):1665-7. doi: 10.1586/ern.11.162. No abstract available.

PMID:
22091590
31.

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, Quiroz YT, Kosik KS, Lopera F, Tariot PN.

J Alzheimers Dis. 2011;26 Suppl 3:321-9. doi: 10.3233/JAD-2011-0059. Review.

32.

Event-related potential markers of brain changes in preclinical familial Alzheimer disease.

Quiroz YT, Ally BA, Celone K, McKeever J, Ruiz-Rizzo AL, Lopera F, Stern CE, Budson AE.

Neurology. 2011 Aug 2;77(5):469-75. doi: 10.1212/WNL.0b013e318227b1b0. Epub 2011 Jul 20.

33.

Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.

Quiroz YT, Budson AE, Celone K, Ruiz A, Newmark R, Castrillón G, Lopera F, Stern CE.

Ann Neurol. 2010 Dec;68(6):865-75. doi: 10.1002/ana.22105. Erratum in: Ann Neurol. 2011 Jul;70(1):187.

34.

ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation.

Bobes MA, García YF, Lopera F, Quiroz YT, Galán L, Vega M, Trujillo N, Valdes-Sosa M, Valdes-Sosa P.

Hum Brain Mapp. 2010 Feb;31(2):247-65. doi: 10.1002/hbm.20861.

PMID:
19650138
35.

Greater working memory load results in greater medial temporal activity at retrieval.

Schon K, Quiroz YT, Hasselmo ME, Stern CE.

Cereb Cortex. 2009 Nov;19(11):2561-71. doi: 10.1093/cercor/bhp006. Epub 2009 Feb 18.

36.

Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families.

Palacio JD, Castellanos FX, Pineda DA, Lopera F, Arcos-Burgos M, Quiroz YT, Henao GC, Puerta IC, Ramírez DL, Rapoport JL, Bailey-Wilson J, Berg K, Muenke M.

J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1506-15.

PMID:
15564820
37.

Statistical analyses of structural magnetic resonance imaging of the head of the caudate nucleus in Colombian children with attention-deficit hyperactivity disorder.

Pineda DA, Restrepo MA, Sarmiento RJ, Gutierrez JE, Vargas SA, Quiroz YT, Hynd GW.

J Child Neurol. 2002 Feb;17(2):97-105.

PMID:
11952084

Supplemental Content

Loading ...
Support Center